PGNY
Progyny, Inc. Common Stock
SERVICES-MISC HEALTH & ALLIED SERVICES, NEC
Progyny (PGNY) Stock: Buy, Sell, or Hold?
$36.18
-0.40 (-1.09%)
▼
5d:
+3.85%
30d:
+31.78%
90d:
+42.83%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Nov 04, 2026
0d
Protect PGNY Gains
Updated Nov 13, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (14%)
Quality Score
32/100
Position
EXTENDED
30-Day Fair Range
$26.18 – $31.84
Position: EXTENDED
Forward P/E & Valuation
15.1x
STRETCHED
vs 11.5x historical avg
Wall Street Target
$37.25
+3.0% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$28.80 / $37.16
Trend: Sideways
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR BETTER ENTRY: PGNY is 13.6% above its trading range ($31.84). Market expects 9.3% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
Get Alerted When PGNY Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$42.12
Based on 8.9% avg growth
INTRINSIC VALUE TODAY
$26.15
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 11.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: PGNY is currently trading at $36.18, which is considered extended relative to its 30-day fair value range of $26.18 to $31.84. From a valuation perspective, the stock is trading at a premium (Forward PE: 15.1) compared to its historical average (11.5). At these levels, the market is pricing in 9.3% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, PGNY is showing sideways momentum. The price is approaching resistance at $37.16. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: PGNY scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, PGNY is showing sideways momentum. The price is approaching resistance at $37.16. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: PGNY scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$26.18 -
$31.84
Company Quality Score
32/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
14.3%
Trading Range & Key Levels
30-Day Trading Range
$26.18 -
$31.84
Current vs Trading Range
EXTENDED
Support Level
$28.80
Resistance Level
$37.16
Current Trend
Sideways
Technical data as of
Nov 13, 2026
Protect Your Profits
PGNY is technically overbought (RSI 79). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanQuantitative Signal Breakdown
- BEARISH: Price significantly overextended (+13.6% above its trading range)
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($37.25)
- NEUTRAL: PE elevated vs history but 9.3% growth expectation is conservative given 113% recent growth
- WARNING: Composite score 32/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
15.06
Wall Street Target
$37.25
(+3.0%)
Revenue Growth (YoY)
8.9%
Earnings Growth (YoY)
113.3%
Profit Margin
6.8%
Valuation Premium vs History
+9.3% premium
PE vs Historical
15.1 vs 11.5
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+9.3%
(market-implied from PE analysis)
1-Year Target
$39.54
(+9%)
2-Year Target
$43.22
(+20%)
3-Year Target
$47.24
(+31%)
3-Yr Target (if PE normalizes)
(PE: 15→12)
PE COMPRESSION
$36.08
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 13.7%)
$70.21
(+94%)
Base:
(SPY PE: 15.1, Growth: 13.7%)
$53.23
(+47%)
Bear:
(PE: 11.5, Growth: 13.7%)
$40.66
(+12%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (33x PE), but valuation improves significantly next year (15x PE) as earnings recover.
Trailing PE: 33.49 | Current EPS (TTM): $1.09
Bull Case
$80.30
(+120%)
Analyst growth 100.0%, PE expands to 36.8
Base Case
$73.00
(+100%)
Market implied 100.0%, PE stable at 33.5
Bear Case
$24.82
(-32%)
Severe decline -20.0%, PE contracts to 28.5
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share PGNY Analysis
Share this live PGNY analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (PGNY)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Oct 26, 2026
Daily AI digest
AI Retail Discussion Summary:
Progyny's new study reveals significant improvement in menopause symptoms for over 70% of members, with the greatest gains observed among those receiving personalized coaching and care from menopause-trained providers.
Key Retail Themes:
Menopause care model
Company study findings
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 13, 2026 5:45 PM ET
Data refreshes hourly during market hours. Next update: 6:45 PM
Data refreshes hourly during market hours. Next update: 6:45 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PGNY showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Healthcare Plans Stocks
Top-rated stocks in Healthcare Plans by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CVS
CVS Health Corp |
STRONG BUY
27 analysts |
$115 | 60 HOLD |
|
UNH
UnitedHealth Group Incor… |
STRONG BUY
26 analysts |
$477 | 55 HOLD |
|
CI
The Cigna Group |
STRONG BUY
24 analysts |
$342 | 46 HOLD |
|
ELV
Elevance Health Inc |
BUY
22 analysts |
$482 | 49 HOLD |
|
HUM
Humana Inc |
BUY
26 analysts |
$465 | 34 SELL |
Advanced PGNY Option Strategies
Professional options setups generated by AI based on today's PGNY price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive PGNY Research Pages
